Overview

Comparison of Diclofenac Systemic Exposure From Two Different Products (AMZ001 and Diclofenac Diethylammonium 1.16% Gel) in Healthy Participants After Repeated Topical Administrations for 7 Days.

Status:
ACTIVE_NOT_RECRUITING

Trial end date:
2025-07-01

Target enrollment:

Participant gender:

Summary

The aim of the present study is to investigate the systemic bioavailability of AMZ001, applied once daily on each knee compared to Diclofenac diethylammonium gel 1.16%, applied 4 times daily on each knee, after repeated dosing in healthy subjects for 7 days The safety and local tolerability of AMZ001, applied once daily, will be evaluated after repeated dosing in healthy subjects for 7 days

Phase:

PHASE1

Details

Lead Sponsor:

Amzell

Treatments:

diclofenac diethylamine
Gels